Persistent Rural-Urban Disparities in Chronic Pain Highlighted by New Study

A new study highlights ongoing disparities in chronic pain between rural and urban populations in the U.S., emphasizing the need for innovative, accessible pain management strategies to address health inequities.
A recent comprehensive study published in The Journal of Rural Health reveals that disparities in the prevalence of chronic pain between rural and urban populations in the United States continue to persist, even after accounting for demographic and socioeconomic factors. Conducted by researchers from the Osher Center for Integrative Health at the University of Vermont and the Maine Rural Health Research Center, the study analyzed data from over 107,000 adults collected between 2019 and 2021.
The findings indicate that rural residents are significantly more affected by chronic pain, with an adjusted prevalence of 23%, compared to 22% in urban populations. Even after adjusting for variables such as age, income, and education, rural individuals had a 9% higher likelihood of experiencing chronic pain. This persistent gap underscores the structural barriers faced by rural communities, including limited access to specialized pain management, higher average age, and lower socioeconomic status.
Chronic pain remains a major health concern, linked to increased risks of opioid misuse, disability, and reduced quality of life. Dr. Joshua Plavin, Medical Director of the Osher Center's Comprehensive Pain Program, emphasizes the urgency of addressing these disparities through innovative and accessible care models. The Center’s flagship initiative, the PATH program, offers a 12- to 16-week integrative approach combining therapies such as mindfulness, physical therapy, acupuncture, and behavioral health support.
PATH is designed to be inclusive and accessible, delivering services via in-person, online, and hybrid formats specifically to reach rural populations. A novel bundled payment model, developed in collaboration with Blue Cross Blue Shield of Vermont, ensures patients pay no more than standard primary care copays, removing financial obstacles.
The impact of these approaches is promising, with participants showing a 70% reduction in emergency department visits within a year after completing the program. Such results highlight the potential of integrative health strategies to reduce healthcare costs and improve outcomes for underserved populations.
The study and its initiatives advocate for systemic reforms in managing chronic pain, especially in rural areas heavily burdened by this condition. As Dr. Rose notes, adopting whole health models not only enhances patient care but also aligns with broader goals of health equity and cost efficiency.
For more insights, the full study details are available at source.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Revolutionizing Brain Research: Graphene-Enhanced Organoids Accelerate Neural Development and Open Pathways for Neurodegenerative Disease Insights
Innovative use of graphene accelerates brain organoid maturation, offering new possibilities for neurodegenerative disease research, brain-machine interfaces, and advanced neurotechnology.
Leveraging Data and Artificial Intelligence to Enhance Healthcare Systems
Discover how data and artificial intelligence are transforming healthcare systems by enabling real-time insights, improving patient outcomes, and fostering system-wide learning for a more efficient and equitable future.
Study Finds Delta-8 THC Use Peaks in States Where Marijuana Is Illegal
Delta-8 THC, a psychoactive alternative to marijuana, is most commonly used in states with restrictive cannabis laws, highlighting how policy gaps may drive consumers toward poorly regulated substances. A new study emphasizes the need for clearer regulations to enhance public safety.
UK Report Highlights Call for More Inclusive and Accessible Medicines Research and Care
A new UK report calls for more inclusive, accessible medicines research and healthcare practices, highlighting stakeholder insights on improving the entire medicines lifecycle from discovery to use.



